Posts for Cogent Biosciences, Inc. ($COGT)

Explore Cogent Biosciences' Q4 2023 financial results, highlighting significant net losses, cash position, and strategic recommendations for investors.

Explore Cogent Biosciences, Inc.'s latest 8-K filing detailing significant corporate events as of February 25, 2025. Key insights for investors and stakeholders.